The role of protein kinase A in the ethanol-induced increase in spontaneous GABA release onto cerebellar Purkinje neurons

J Neurophysiol. 2008 Dec;100(6):3417-28. doi: 10.1152/jn.90970.2008. Epub 2008 Oct 22.

Abstract

Ethanol increases miniature inhibitory postsynaptic current frequency and decreases the paired-pulse ratio, which suggests that ethanol increases both spontaneous and evoked GABA release, respectively. We have shown previously that ethanol increases GABA release at the rat interneuron-Purkinje cell synapse and that this ethanol effect involves calcium release from internal stores; however, further exploration of the mechanism responsible for ethanol-enhanced GABA release was needed. We found that a cannabinoid receptor 1 (CB1) agonist, WIN-55212, and a GABA(B) receptor agonist, baclofen, decreased baseline spontaneous GABA release and prevented ethanol from increasing spontaneous GABA release. The CB1 receptor and GABA(B) receptor are Galpha i-linked G protein-coupled receptors with common downstream messengers that include adenylate cyclase and protein kinase A (PKA). Adenylate cyclase and PKA antagonists blocked ethanol from increasing spontaneous GABA release, whereas a PKA antagonist limited to the postsynaptic neuron did not block ethanol from increasing spontaneous GABA release. These results suggest that presynaptic PKA plays an essential role in ethanol-enhanced spontaneous GABA release. Similar to ethanol, we found that the mechanism of the cannabinoid-mediated decrease in spontaneous GABA release involves internal calcium stores and PKA. A PKA antagonist decreased baseline spontaneous GABA release. This effect was reduced after incubating the slice with a calcium chelator, BAPTA-AM, but was unaffected when BAPTA was limited to the postsynaptic neuron. This suggests that the PKA antagonist is acting through a presynaptic, calcium-dependent mechanism to decrease spontaneous GABA release. Overall, these results suggest that PKA activation is necessary for ethanol to increase spontaneous GABA release.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Animals, Newborn
  • Baclofen / pharmacology
  • Benzoxazines / pharmacology
  • Benzylamines / pharmacology
  • Calcium / metabolism
  • Central Nervous System Depressants / pharmacology*
  • Cerebellum / cytology*
  • Dose-Response Relationship, Drug
  • Electric Stimulation / methods
  • Enzyme Inhibitors / pharmacology
  • Ethanol / pharmacology*
  • GABA Agents / pharmacology
  • In Vitro Techniques
  • Inhibitory Postsynaptic Potentials / drug effects
  • Inhibitory Postsynaptic Potentials / physiology
  • Membrane Potentials / drug effects
  • Membrane Potentials / physiology
  • Morpholines / pharmacology
  • Naphthalenes / pharmacology
  • Patch-Clamp Techniques
  • Phosphinic Acids / pharmacology
  • Protein Kinase C / physiology*
  • Purkinje Cells / drug effects*
  • Rats
  • Rats, Sprague-Dawley
  • Sodium Channel Blockers / pharmacology
  • Tetrodotoxin / pharmacology
  • gamma-Aminobutyric Acid / metabolism*

Substances

  • Benzoxazines
  • Benzylamines
  • Central Nervous System Depressants
  • Enzyme Inhibitors
  • GABA Agents
  • Morpholines
  • Naphthalenes
  • Phosphinic Acids
  • Sodium Channel Blockers
  • CGP 52432
  • Ethanol
  • Tetrodotoxin
  • gamma-Aminobutyric Acid
  • (3R)-((2,3-dihydro-5-methyl-3-((4-morpholinyl)methyl)pyrrolo-(1,2,3-de)-1,4-benzoxazin-6-yl)(1-naphthalenyl))methanone
  • Protein Kinase C
  • Baclofen
  • Calcium